Replies to post #69672 on Cytodyn Inc (CYDY)

[Dieselpro]

Why do you post this nonsense? Again it's a bio company, once they've met their endpoints the past is meaningless. And those numbers look pretty damn good 200 million is nothing to develop a drug. Looks like Cytodyn is doing an excellent job, only spending 200 million for a drug value in multi billions.

[Venture_Cap]

Their loss

[Bobbyinvest]

Giving up is not an option any longer. 10 years ago is 10 years ago. It was based on preliminary IRR and NPV calculated returns, it’s fundamentals of investment management.

To get over the past, you first have to accept that the past is over.... Leronlimab is the future.

[Blane]

You’re right “Justafactss”, context is key.

“Little Cyto Dyn and its shareholders bought this product with $3.5 million dollars down payment and in the next 8 years we raised about two hundred and fifty million dollars. Today there is no doubt with our current stock price and unbelievable potential future in NASH, GvHD, HIV treatment, HIV prevention, and cancer, that our shareholders were right to trust CytoDyn management. Progenics fully diluted market cap is now about $450 million dollars. While CytoDyn’s fully diluted market cap as of today is about $600 million. I congratulate all our shareholders for trusting the CytoDyn team for trusting the fundamentals, for trusting the truth today. We are so proud that we are blessed to try to save a few lives in cancer and maybe a lot more very soon.“

See? I can cherry pick too. The only difference is your quote is from Nader quoting the past, before he became CEO. My quote is from the now.